NOVACODE serial ECG classification system for clinical trials and epidemiologic studies.
about
Design of a trial evaluating myocardial cell protection with cariporide, an inhibitor of the transmembrane sodium-hydrogen exchanger: the Guard During Ischemia Against Necrosis (GUARDIAN) trialThe association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD studyThe Bypass Angioplasty Revascularization Investigation 2 Diabetes randomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemic heart disease: impact of treatment strategy on cardiac mortality and myocardial infRacial differences in atrial fibrillation prevalence and left atrial sizeThe Carotid Revascularization Endarterectomy versus Stenting Trial: credentialing of interventionalists and final results of lead-in phaseStatin use is associated with lower risk of atrial fibrillation in women with coronary disease: the HERS trial.The association among autonomic nervous system function, incident diabetes, and intervention arm in the Diabetes Prevention Program.Association of Sleep Apnea and Snoring With Incident Atrial Fibrillation in the Multi-Ethnic Study of AtherosclerosisPrediction and classification of cardiovascular disease risk in older adults with diabetes.Prognostic significance of serial Q/ST-T changes by the Minnesota Code and Novacode in the Atherosclerosis Risk in Communities (ARIC) study.Fibroblast growth factor 23, left ventricular mass, and left ventricular hypertrophy in community-dwelling older adults.Gender-related differences in electrocardiographic parameters and their association with cardiac events in patients after myocardial infarction.Increased Hazard of Myocardial Infarction With Insulin-Provision Therapy in Actively Smoking Patients With Diabetes Mellitus and Stable Ischemic Heart Disease: The BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) Trial.
P2860
Q24804464-64882E8C-BAFF-4501-8CFB-03BCD1C40F78Q33579765-EA55F17E-4068-4666-8F68-905033066DB0Q33696402-8ECCC1AF-845A-4363-8DB9-C010B10B408AQ33900034-452FDE62-3875-4B48-8C07-9E32231D36C1Q34102771-95BA9D9C-E3AF-4D52-9A92-1757E437B28AQ35207701-362BCF18-2EF6-43E1-94EB-BA737F8A7BFEQ35546312-DECFBA78-6713-4269-846A-796F88E7121CQ35775692-0AC51065-7B84-4AD3-8A75-944537A18CAAQ36511029-802B1791-09A3-44AB-9ED1-7FA6BB7288A2Q37103077-129E39EB-E3CC-41DD-AFEB-577DF667A64CQ37342971-5EA79FF5-EB74-499C-A884-9FDA73F209F9Q37383235-9F283D2F-C6F7-4B93-8069-301CE25E172CQ42373687-B7E7C090-9382-4B84-96D7-D42B23C2A4A6
P2860
NOVACODE serial ECG classification system for clinical trials and epidemiologic studies.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh-hant
name
NOVACODE serial ECG classification system for clinical trials and epidemiologic studies.
@en
NOVACODE serial ECG classification system for clinical trials and epidemiologic studies.
@nl
type
label
NOVACODE serial ECG classification system for clinical trials and epidemiologic studies.
@en
NOVACODE serial ECG classification system for clinical trials and epidemiologic studies.
@nl
prefLabel
NOVACODE serial ECG classification system for clinical trials and epidemiologic studies.
@en
NOVACODE serial ECG classification system for clinical trials and epidemiologic studies.
@nl
P2093
P1476
NOVACODE serial ECG classification system for clinical trials and epidemiologic studies.
@en
P2093
Calhoun HP
Chaitman BR
Rautaharju PM
P304
P478
P577
1992-01-01T00:00:00Z